Meetings and Workshops

Agenda for the November 19, 2007 Carcinogen Identification Committee meeting.

As part of an ongoing project to clarify and update these regulatory provisions, OEHHA has established a limited-term position for a regulatory attorney. OEHHA is seeking input from stakeholders in the enforcement and business communities, as well as other members of the public concerning the direction this effort should take.

Request for comments on the proposed listing of gallium arsenide as known to cause cancer and hexafluoroacetone, nitrous oxide and vinyl cyclohexene dioxide as known to cause reproductive toxicity; and notice of a public workshop on the proposed listing of chemicals via the Labor Code provision.

NOTE: Following the March 23, 2005 Safe Use Determination public hearing, OEHHA determined that issuance of an Interpretive Guideline would be the more appropriate course of action.

Proposal to establish a specific regulatory level having no observable effect for di(2-ethylhexyl)phthalate (DEHP) and amend Title 22, California Code of Regulations, Section 12805.

November 4, 2004 Meeting of the Science Advisory Board’s Developmental and Reproductive Toxicant (DART) Identification Committee

Tentative agenda for the November 1, 2004 meeting of the Science Advisory Board’s Carcinogen Identification Committee.

Final agenda for the workshop on Proposition 65 regulatory options regarding acrylamide in food

December 18, 2001 meeting of the Science Advisory Board's Carcinogen Identification Committee (CIC) for consideration of chemicals as known to the state to cause cancer:Allyl isovalerate, N-carboxymethyl-N-nitrosourea, and removal of chemicals from the list: PCP, maneb, and propachlor.

December 17, 2001 Meeting of the Science Advisory Board's Developmental and Reproductive Toxicant (DART) Identification Committee to: elect a chair; consider the listing of Metribuzin, cyclohexanol, and 2,4-DP for reproductive toxicity; and to consider the removal from the Section 14000 list for t: N- methylpyrrolidone (tera), diclofop methyl (tera), dinocap (tera), fluvalinate (tera), nitrapyrin (tera), and triadimefon (repro) and 1,6-Hexamethylene diisocyanate (rtox, tera).